GlassScriptPhysician profile
Alexandria Hellmich
NPI 1386147247
$12,564.73
in general payments reported to CMS, 2019-2025
39 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,341 · 2022: $4,785 · 2023: $1,955 · 2024: $1,172 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,317.50 | 2021-2023 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Novo Nordisk INC | $2,156.50 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,597.54 | 2021-2024 | Mounjaro, Jardiance, Lyumjev |
| Astrazeneca Pharmaceuticals LP | $476.17 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $474.32 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $464.77 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.76 | 2021-2024 | Jardiance |
| Abbott Laboratories | $437.64 | 2021-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $369.94 | 2021-2024 | Korlym |
| Abbvie INC. | $356.59 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $339.63 | 2021-2024 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $333.08 | 2021-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $318.60 | 2021-2023 | Prolia, Evenity, Repatha |
| Esperion Therapeutics, INC. | $217.78 | 2021-2024 | Nexletol |
| Becton, Dickinson and Company | $187.20 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandria Hellmich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.